nodes	percent_of_prediction	percent_of_DWPC	metapath
Methimazole—CYP2A6—prostate cancer	0.134	0.35	CbGaD
Methimazole—CYP2E1—prostate cancer	0.0951	0.248	CbGaD
Methimazole—CYP2C19—prostate cancer	0.0942	0.246	CbGaD
Methimazole—CYP3A4—prostate cancer	0.0599	0.156	CbGaD
Methimazole—CYP2C19—Bicalutamide—prostate cancer	0.0226	0.0545	CbGbCtD
Methimazole—CYP2C19—Nilutamide—prostate cancer	0.0226	0.0545	CbGbCtD
Methimazole—CYP2E1—Estrone—prostate cancer	0.0216	0.052	CbGbCtD
Methimazole—CYP2B6—Estrone—prostate cancer	0.0213	0.0513	CbGbCtD
Methimazole—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0208	0.0501	CbGbCtD
Methimazole—CYP2B6—Ethinyl Estradiol—prostate cancer	0.019	0.0458	CbGbCtD
Methimazole—CYP2C9—Nilutamide—prostate cancer	0.0188	0.0453	CbGbCtD
Methimazole—CYP2C9—Bicalutamide—prostate cancer	0.0188	0.0453	CbGbCtD
Methimazole—CYP2C19—Flutamide—prostate cancer	0.0188	0.0451	CbGbCtD
Methimazole—CYP1A2—Flutamide—prostate cancer	0.0173	0.0416	CbGbCtD
Methimazole—CYP2D6—Bicalutamide—prostate cancer	0.0172	0.0414	CbGbCtD
Methimazole—CYP2D6—Abiraterone—prostate cancer	0.0143	0.0343	CbGbCtD
Methimazole—CYP2E1—Mitoxantrone—prostate cancer	0.0129	0.031	CbGbCtD
Methimazole—CYP1A2—Estrone—prostate cancer	0.0125	0.0301	CbGbCtD
Methimazole—CYP2C9—Estrone—prostate cancer	0.0113	0.0271	CbGbCtD
Methimazole—CYP3A4—Bicalutamide—prostate cancer	0.0109	0.0263	CbGbCtD
Methimazole—CYP3A4—Estramustine—prostate cancer	0.0102	0.0245	CbGbCtD
Methimazole—CYP3A4—Flutamide—prostate cancer	0.00907	0.0218	CbGbCtD
Methimazole—CYP3A4—Abiraterone—prostate cancer	0.00907	0.0218	CbGbCtD
Methimazole—CYP2C9—Capecitabine—prostate cancer	0.00855	0.0206	CbGbCtD
Methimazole—CYP1A2—Conjugated Estrogens—prostate cancer	0.00819	0.0197	CbGbCtD
Methimazole—CYP2E1—Etoposide—prostate cancer	0.00811	0.0195	CbGbCtD
Methimazole—CYP2C19—Estradiol—prostate cancer	0.00779	0.0187	CbGbCtD
Methimazole—CYP1A2—Estradiol—prostate cancer	0.00719	0.0173	CbGbCtD
Methimazole—CYP3A4—Cabazitaxel—prostate cancer	0.00671	0.0161	CbGbCtD
Methimazole—CYP2C19—Prednisone—prostate cancer	0.0067	0.0161	CbGbCtD
Methimazole—CYP3A4—Estrone—prostate cancer	0.00656	0.0158	CbGbCtD
Methimazole—CYP2C9—Estradiol—prostate cancer	0.00648	0.0156	CbGbCtD
Methimazole—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00584	0.0141	CbGbCtD
Methimazole—CYP2B6—Doxorubicin—prostate cancer	0.00546	0.0131	CbGbCtD
Methimazole—CYP1A2—Etoposide—prostate cancer	0.00469	0.0113	CbGbCtD
Methimazole—CYP3A4—Conjugated Estrogens—prostate cancer	0.00429	0.0103	CbGbCtD
Methimazole—CYP3A4—Mitoxantrone—prostate cancer	0.0039	0.00938	CbGbCtD
Methimazole—CYP3A4—Estradiol—prostate cancer	0.00377	0.00906	CbGbCtD
Methimazole—CYP3A4—Prednisone—prostate cancer	0.00324	0.00779	CbGbCtD
Methimazole—CYP2D6—Doxorubicin—prostate cancer	0.00264	0.00634	CbGbCtD
Methimazole—CYP3A4—Etoposide—prostate cancer	0.00246	0.00591	CbGbCtD
Methimazole—CYP3A4—Docetaxel—prostate cancer	0.00225	0.00541	CbGbCtD
Methimazole—CYP2C19—urine—prostate cancer	0.00196	0.124	CbGeAlD
Methimazole—CYP3A4—Doxorubicin—prostate cancer	0.00168	0.00403	CbGbCtD
Methimazole—CYP1A2—urine—prostate cancer	0.0016	0.101	CbGeAlD
Methimazole—CYP2C9—urine—prostate cancer	0.00152	0.0962	CbGeAlD
Methimazole—CYP2E1—urine—prostate cancer	0.00144	0.0912	CbGeAlD
Methimazole—TPO—testis—prostate cancer	0.00133	0.0839	CbGeAlD
Methimazole—CYP3A4—urine—prostate cancer	0.00116	0.0734	CbGeAlD
Methimazole—CYP2D6—urine—prostate cancer	0.00114	0.0722	CbGeAlD
Methimazole—CYP2A6—prostate gland—prostate cancer	0.00109	0.0693	CbGeAlD
Methimazole—CYP2A6—seminal vesicle—prostate cancer	0.000926	0.0586	CbGeAlD
Methimazole—CYP2E1—prostate gland—prostate cancer	0.000517	0.0327	CbGeAlD
Methimazole—CYP2E1—seminal vesicle—prostate cancer	0.000438	0.0277	CbGeAlD
Methimazole—CYP1A2—renal system—prostate cancer	0.000392	0.0248	CbGeAlD
Methimazole—CYP2B6—renal system—prostate cancer	0.000376	0.0238	CbGeAlD
Methimazole—CYP2E1—renal system—prostate cancer	0.000353	0.0223	CbGeAlD
Methimazole—CYP2E1—urethra—prostate cancer	0.000346	0.0219	CbGeAlD
Methimazole—CYP3A4—renal system—prostate cancer	0.000284	0.0179	CbGeAlD
Methimazole—CYP2D6—renal system—prostate cancer	0.000279	0.0177	CbGeAlD
Methimazole—Vomiting—Nilutamide—prostate cancer	0.00027	0.00331	CcSEcCtD
Methimazole—Dyspepsia—Bicalutamide—prostate cancer	0.00027	0.00331	CcSEcCtD
Methimazole—Vomiting—Flutamide—prostate cancer	0.000269	0.0033	CcSEcCtD
Methimazole—Pruritus—Degarelix—prostate cancer	0.000269	0.00329	CcSEcCtD
Methimazole—Rash—Nilutamide—prostate cancer	0.000268	0.00328	CcSEcCtD
Methimazole—Dermatitis—Nilutamide—prostate cancer	0.000268	0.00328	CcSEcCtD
Methimazole—Rash—Flutamide—prostate cancer	0.000267	0.00327	CcSEcCtD
Methimazole—Dermatitis—Flutamide—prostate cancer	0.000267	0.00327	CcSEcCtD
Methimazole—Headache—Nilutamide—prostate cancer	0.000266	0.00326	CcSEcCtD
Methimazole—Alopecia—Goserelin—prostate cancer	0.000266	0.00325	CcSEcCtD
Methimazole—Headache—Flutamide—prostate cancer	0.000265	0.00325	CcSEcCtD
Methimazole—Alopecia—Conjugated Estrogens—prostate cancer	0.000263	0.00322	CcSEcCtD
Methimazole—Neuropathy peripheral—Estradiol—prostate cancer	0.00026	0.00319	CcSEcCtD
Methimazole—Oedema—Ethinyl Estradiol—prostate cancer	0.00026	0.00318	CcSEcCtD
Methimazole—Jaundice—Estradiol—prostate cancer	0.000259	0.00317	CcSEcCtD
Methimazole—Neuritis—Doxorubicin—prostate cancer	0.000256	0.00313	CcSEcCtD
Methimazole—Ageusia—Epirubicin—prostate cancer	0.000254	0.00312	CcSEcCtD
Methimazole—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000254	0.00311	CcSEcCtD
Methimazole—Nausea—Nilutamide—prostate cancer	0.000253	0.00309	CcSEcCtD
Methimazole—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000252	0.00309	CcSEcCtD
Methimazole—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000252	0.00308	CcSEcCtD
Methimazole—Nausea—Flutamide—prostate cancer	0.000251	0.00308	CcSEcCtD
Methimazole—Headache—Estradiol valerate/Dienogest—prostate cancer	0.00025	0.00307	CcSEcCtD
Methimazole—Drowsiness—Mitoxantrone—prostate cancer	0.000247	0.00303	CcSEcCtD
Methimazole—Urticaria—Bicalutamide—prostate cancer	0.000244	0.00299	CcSEcCtD
Methimazole—CYP2B6—testis—prostate cancer	0.000243	0.0154	CbGeAlD
Methimazole—Body temperature increased—Bicalutamide—prostate cancer	0.000243	0.00297	CcSEcCtD
Methimazole—Vomiting—Degarelix—prostate cancer	0.000242	0.00296	CcSEcCtD
Methimazole—Jaundice—Mitoxantrone—prostate cancer	0.000241	0.00295	CcSEcCtD
Methimazole—Rash—Degarelix—prostate cancer	0.00024	0.00293	CcSEcCtD
Methimazole—Dermatitis—Degarelix—prostate cancer	0.000239	0.00293	CcSEcCtD
Methimazole—Hepatitis—Estradiol—prostate cancer	0.000238	0.00292	CcSEcCtD
Methimazole—Headache—Degarelix—prostate cancer	0.000238	0.00292	CcSEcCtD
Methimazole—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000237	0.00291	CcSEcCtD
Methimazole—Ageusia—Doxorubicin—prostate cancer	0.000235	0.00288	CcSEcCtD
Methimazole—Leukopenia—Goserelin—prostate cancer	0.000234	0.00287	CcSEcCtD
Methimazole—Vertigo—Conjugated Estrogens—prostate cancer	0.000233	0.00285	CcSEcCtD
Methimazole—Agranulocytosis—Mitoxantrone—prostate cancer	0.000231	0.00283	CcSEcCtD
Methimazole—CYP2E1—testis—prostate cancer	0.000228	0.0144	CbGeAlD
Methimazole—Vomiting—Cabazitaxel—prostate cancer	0.000228	0.00279	CcSEcCtD
Methimazole—Nausea—Degarelix—prostate cancer	0.000226	0.00276	CcSEcCtD
Methimazole—Headache—Cabazitaxel—prostate cancer	0.000224	0.00275	CcSEcCtD
Methimazole—Arthralgia—Goserelin—prostate cancer	0.000223	0.00273	CcSEcCtD
Methimazole—Myalgia—Goserelin—prostate cancer	0.000223	0.00273	CcSEcCtD
Methimazole—Hepatitis—Mitoxantrone—prostate cancer	0.000222	0.00272	CcSEcCtD
Methimazole—Arthralgia—Conjugated Estrogens—prostate cancer	0.000221	0.0027	CcSEcCtD
Methimazole—Myalgia—Conjugated Estrogens—prostate cancer	0.000221	0.0027	CcSEcCtD
Methimazole—Pruritus—Bicalutamide—prostate cancer	0.000217	0.00266	CcSEcCtD
Methimazole—Oedema—Goserelin—prostate cancer	0.000214	0.00262	CcSEcCtD
Methimazole—Nausea—Cabazitaxel—prostate cancer	0.000213	0.0026	CcSEcCtD
Methimazole—Oedema—Conjugated Estrogens—prostate cancer	0.000212	0.00259	CcSEcCtD
Methimazole—Alopecia—Estradiol—prostate cancer	0.000211	0.00258	CcSEcCtD
Methimazole—Thrombocytopenia—Goserelin—prostate cancer	0.000209	0.00256	CcSEcCtD
Methimazole—Urticaria—Ethinyl Estradiol—prostate cancer	0.000206	0.00253	CcSEcCtD
Methimazole—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.000205	0.00251	CcSEcCtD
Methimazole—Neuropathy peripheral—Etoposide—prostate cancer	0.000202	0.00247	CcSEcCtD
Methimazole—Jaundice—Etoposide—prostate cancer	0.000201	0.00246	CcSEcCtD
Methimazole—Alopecia—Mitoxantrone—prostate cancer	0.000196	0.0024	CcSEcCtD
Methimazole—Vomiting—Bicalutamide—prostate cancer	0.000195	0.00239	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Goserelin—prostate cancer	0.000195	0.00238	CcSEcCtD
Methimazole—Rash—Bicalutamide—prostate cancer	0.000194	0.00237	CcSEcCtD
Methimazole—Aplastic anaemia—Epirubicin—prostate cancer	0.000194	0.00237	CcSEcCtD
Methimazole—Dermatitis—Bicalutamide—prostate cancer	0.000193	0.00237	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Conjugated Estrogens—prostate cancer	0.000193	0.00236	CcSEcCtD
Methimazole—Headache—Bicalutamide—prostate cancer	0.000192	0.00236	CcSEcCtD
Methimazole—Agranulocytosis—Etoposide—prostate cancer	0.000192	0.00235	CcSEcCtD
Methimazole—Paraesthesia—Goserelin—prostate cancer	0.000192	0.00235	CcSEcCtD
Methimazole—Paraesthesia—Conjugated Estrogens—prostate cancer	0.00019	0.00233	CcSEcCtD
Methimazole—Somnolence—Goserelin—prostate cancer	0.00019	0.00233	CcSEcCtD
Methimazole—Somnolence—Conjugated Estrogens—prostate cancer	0.000188	0.0023	CcSEcCtD
Methimazole—Dyspepsia—Goserelin—prostate cancer	0.000188	0.0023	CcSEcCtD
Methimazole—Vertigo—Estradiol—prostate cancer	0.000186	0.00228	CcSEcCtD
Methimazole—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000186	0.00228	CcSEcCtD
Methimazole—Pruritus—Ethinyl Estradiol—prostate cancer	0.000184	0.00225	CcSEcCtD
Methimazole—Nausea—Bicalutamide—prostate cancer	0.000182	0.00223	CcSEcCtD
Methimazole—CYP2D6—testis—prostate cancer	0.00018	0.0114	CbGeAlD
Methimazole—Aplastic anaemia—Doxorubicin—prostate cancer	0.000179	0.00219	CcSEcCtD
Methimazole—Arthralgia—Estradiol—prostate cancer	0.000177	0.00216	CcSEcCtD
Methimazole—Myalgia—Estradiol—prostate cancer	0.000177	0.00216	CcSEcCtD
Methimazole—Lymphadenopathy—Epirubicin—prostate cancer	0.000175	0.00215	CcSEcCtD
Methimazole—Leukopenia—Mitoxantrone—prostate cancer	0.000173	0.00212	CcSEcCtD
Methimazole—Urticaria—Goserelin—prostate cancer	0.00017	0.00208	CcSEcCtD
Methimazole—Oedema—Estradiol—prostate cancer	0.000169	0.00207	CcSEcCtD
Methimazole—Body temperature increased—Goserelin—prostate cancer	0.000169	0.00207	CcSEcCtD
Methimazole—Urticaria—Conjugated Estrogens—prostate cancer	0.000168	0.00206	CcSEcCtD
Methimazole—Neuropathy peripheral—Docetaxel—prostate cancer	0.000168	0.00205	CcSEcCtD
Methimazole—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000167	0.00205	CcSEcCtD
Methimazole—Jaundice—Docetaxel—prostate cancer	0.000167	0.00204	CcSEcCtD
Methimazole—Vomiting—Ethinyl Estradiol—prostate cancer	0.000165	0.00202	CcSEcCtD
Methimazole—Myalgia—Mitoxantrone—prostate cancer	0.000165	0.00202	CcSEcCtD
Methimazole—Arthralgia—Mitoxantrone—prostate cancer	0.000165	0.00202	CcSEcCtD
Methimazole—Rash—Ethinyl Estradiol—prostate cancer	0.000164	0.002	CcSEcCtD
Methimazole—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000163	0.002	CcSEcCtD
Methimazole—Alopecia—Etoposide—prostate cancer	0.000163	0.002	CcSEcCtD
Methimazole—Headache—Ethinyl Estradiol—prostate cancer	0.000163	0.00199	CcSEcCtD
Methimazole—Lymphadenopathy—Doxorubicin—prostate cancer	0.000162	0.00199	CcSEcCtD
Methimazole—Neuropathy peripheral—Capecitabine—prostate cancer	0.000162	0.00199	CcSEcCtD
Methimazole—Jaundice—Capecitabine—prostate cancer	0.000161	0.00198	CcSEcCtD
Methimazole—Agranulocytosis—Docetaxel—prostate cancer	0.00016	0.00195	CcSEcCtD
Methimazole—Oedema—Mitoxantrone—prostate cancer	0.000158	0.00193	CcSEcCtD
Methimazole—Agranulocytosis—Capecitabine—prostate cancer	0.000154	0.00189	CcSEcCtD
Methimazole—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000154	0.00189	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000154	0.00189	CcSEcCtD
Methimazole—Nausea—Ethinyl Estradiol—prostate cancer	0.000154	0.00189	CcSEcCtD
Methimazole—Hepatitis—Docetaxel—prostate cancer	0.000153	0.00188	CcSEcCtD
Methimazole—Paraesthesia—Estradiol—prostate cancer	0.000152	0.00186	CcSEcCtD
Methimazole—Pruritus—Goserelin—prostate cancer	0.000151	0.00185	CcSEcCtD
Methimazole—Somnolence—Estradiol—prostate cancer	0.000151	0.00184	CcSEcCtD
Methimazole—Pruritus—Conjugated Estrogens—prostate cancer	0.00015	0.00183	CcSEcCtD
Methimazole—Dyspepsia—Estradiol—prostate cancer	0.000149	0.00183	CcSEcCtD
Methimazole—Hepatitis—Capecitabine—prostate cancer	0.000149	0.00182	CcSEcCtD
Methimazole—Neuropathy peripheral—Prednisone—prostate cancer	0.000145	0.00177	CcSEcCtD
Methimazole—Vertigo—Etoposide—prostate cancer	0.000144	0.00177	CcSEcCtD
Methimazole—Leukopenia—Etoposide—prostate cancer	0.000144	0.00176	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000144	0.00176	CcSEcCtD
Methimazole—Paraesthesia—Mitoxantrone—prostate cancer	0.000142	0.00174	CcSEcCtD
Methimazole—Somnolence—Mitoxantrone—prostate cancer	0.00014	0.00172	CcSEcCtD
Methimazole—Dyspepsia—Mitoxantrone—prostate cancer	0.000139	0.0017	CcSEcCtD
Methimazole—Vomiting—Goserelin—prostate cancer	0.000136	0.00166	CcSEcCtD
Methimazole—Alopecia—Docetaxel—prostate cancer	0.000136	0.00166	CcSEcCtD
Methimazole—Rash—Goserelin—prostate cancer	0.000135	0.00165	CcSEcCtD
Methimazole—Dermatitis—Goserelin—prostate cancer	0.000135	0.00165	CcSEcCtD
Methimazole—Vomiting—Conjugated Estrogens—prostate cancer	0.000135	0.00165	CcSEcCtD
Methimazole—Urticaria—Estradiol—prostate cancer	0.000135	0.00165	CcSEcCtD
Methimazole—Body temperature increased—Estradiol—prostate cancer	0.000134	0.00164	CcSEcCtD
Methimazole—Headache—Goserelin—prostate cancer	0.000134	0.00164	CcSEcCtD
Methimazole—Rash—Conjugated Estrogens—prostate cancer	0.000133	0.00163	CcSEcCtD
Methimazole—Dermatitis—Conjugated Estrogens—prostate cancer	0.000133	0.00163	CcSEcCtD
Methimazole—Headache—Conjugated Estrogens—prostate cancer	0.000133	0.00162	CcSEcCtD
Methimazole—Alopecia—Capecitabine—prostate cancer	0.000131	0.00161	CcSEcCtD
Methimazole—Thrombocytopenia—Etoposide—prostate cancer	0.000128	0.00157	CcSEcCtD
Methimazole—Nausea—Goserelin—prostate cancer	0.000127	0.00155	CcSEcCtD
Methimazole—Nausea—Conjugated Estrogens—prostate cancer	0.000126	0.00154	CcSEcCtD
Methimazole—Urticaria—Mitoxantrone—prostate cancer	0.000125	0.00154	CcSEcCtD
Methimazole—Body temperature increased—Mitoxantrone—prostate cancer	0.000125	0.00153	CcSEcCtD
Methimazole—Pruritus—Estradiol—prostate cancer	0.00012	0.00147	CcSEcCtD
Methimazole—Leukopenia—Docetaxel—prostate cancer	0.00012	0.00147	CcSEcCtD
Methimazole—Paraesthesia—Etoposide—prostate cancer	0.000118	0.00144	CcSEcCtD
Methimazole—Alopecia—Prednisone—prostate cancer	0.000117	0.00143	CcSEcCtD
Methimazole—Somnolence—Etoposide—prostate cancer	0.000117	0.00143	CcSEcCtD
Methimazole—Vertigo—Capecitabine—prostate cancer	0.000116	0.00142	CcSEcCtD
Methimazole—Leukopenia—Capecitabine—prostate cancer	0.000116	0.00142	CcSEcCtD
Methimazole—Drowsiness—Epirubicin—prostate cancer	0.000115	0.00141	CcSEcCtD
Methimazole—Myalgia—Docetaxel—prostate cancer	0.000114	0.00139	CcSEcCtD
Methimazole—Arthralgia—Docetaxel—prostate cancer	0.000114	0.00139	CcSEcCtD
Methimazole—Neuropathy peripheral—Epirubicin—prostate cancer	0.000113	0.00138	CcSEcCtD
Methimazole—Jaundice—Epirubicin—prostate cancer	0.000112	0.00138	CcSEcCtD
Methimazole—Arthralgia—Capecitabine—prostate cancer	0.00011	0.00135	CcSEcCtD
Methimazole—Myalgia—Capecitabine—prostate cancer	0.00011	0.00135	CcSEcCtD
Methimazole—Oedema—Docetaxel—prostate cancer	0.000109	0.00134	CcSEcCtD
Methimazole—Vomiting—Estradiol—prostate cancer	0.000108	0.00132	CcSEcCtD
Methimazole—Agranulocytosis—Epirubicin—prostate cancer	0.000108	0.00132	CcSEcCtD
Methimazole—Thrombocytopenia—Docetaxel—prostate cancer	0.000107	0.00131	CcSEcCtD
Methimazole—Rash—Estradiol—prostate cancer	0.000107	0.00131	CcSEcCtD
Methimazole—Drowsiness—Doxorubicin—prostate cancer	0.000107	0.00131	CcSEcCtD
Methimazole—Dermatitis—Estradiol—prostate cancer	0.000107	0.00131	CcSEcCtD
Methimazole—Headache—Estradiol—prostate cancer	0.000106	0.0013	CcSEcCtD
Methimazole—Oedema—Capecitabine—prostate cancer	0.000106	0.00129	CcSEcCtD
Methimazole—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000105	0.00128	CcSEcCtD
Methimazole—Urticaria—Etoposide—prostate cancer	0.000104	0.00128	CcSEcCtD
Methimazole—Jaundice—Doxorubicin—prostate cancer	0.000104	0.00127	CcSEcCtD
Methimazole—Body temperature increased—Etoposide—prostate cancer	0.000104	0.00127	CcSEcCtD
Methimazole—Vertigo—Prednisone—prostate cancer	0.000104	0.00127	CcSEcCtD
Methimazole—Hepatitis—Epirubicin—prostate cancer	0.000104	0.00127	CcSEcCtD
Methimazole—Thrombocytopenia—Capecitabine—prostate cancer	0.000103	0.00127	CcSEcCtD
Methimazole—Nausea—Estradiol—prostate cancer	0.000101	0.00123	CcSEcCtD
Methimazole—Vomiting—Mitoxantrone—prostate cancer	0.0001	0.00123	CcSEcCtD
Methimazole—Agranulocytosis—Doxorubicin—prostate cancer	9.96e-05	0.00122	CcSEcCtD
Methimazole—Rash—Mitoxantrone—prostate cancer	9.95e-05	0.00122	CcSEcCtD
Methimazole—Dermatitis—Mitoxantrone—prostate cancer	9.94e-05	0.00122	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Docetaxel—prostate cancer	9.94e-05	0.00122	CcSEcCtD
Methimazole—Headache—Mitoxantrone—prostate cancer	9.88e-05	0.00121	CcSEcCtD
Methimazole—Arthralgia—Prednisone—prostate cancer	9.81e-05	0.0012	CcSEcCtD
Methimazole—Myalgia—Prednisone—prostate cancer	9.81e-05	0.0012	CcSEcCtD
Methimazole—Paraesthesia—Docetaxel—prostate cancer	9.79e-05	0.0012	CcSEcCtD
Methimazole—Somnolence—Docetaxel—prostate cancer	9.69e-05	0.00119	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Capecitabine—prostate cancer	9.62e-05	0.00118	CcSEcCtD
Methimazole—Dyspepsia—Docetaxel—prostate cancer	9.6e-05	0.00118	CcSEcCtD
Methimazole—Hepatitis—Doxorubicin—prostate cancer	9.58e-05	0.00117	CcSEcCtD
Methimazole—Paraesthesia—Capecitabine—prostate cancer	9.48e-05	0.00116	CcSEcCtD
Methimazole—Oedema—Prednisone—prostate cancer	9.4e-05	0.00115	CcSEcCtD
Methimazole—Nausea—Mitoxantrone—prostate cancer	9.37e-05	0.00115	CcSEcCtD
Methimazole—Dyspepsia—Capecitabine—prostate cancer	9.29e-05	0.00114	CcSEcCtD
Methimazole—Pruritus—Etoposide—prostate cancer	9.28e-05	0.00114	CcSEcCtD
Methimazole—Alopecia—Epirubicin—prostate cancer	9.15e-05	0.00112	CcSEcCtD
Methimazole—Body temperature increased—Docetaxel—prostate cancer	8.62e-05	0.00106	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Prednisone—prostate cancer	8.57e-05	0.00105	CcSEcCtD
Methimazole—Alopecia—Doxorubicin—prostate cancer	8.47e-05	0.00104	CcSEcCtD
Methimazole—Paraesthesia—Prednisone—prostate cancer	8.44e-05	0.00103	CcSEcCtD
Methimazole—Urticaria—Capecitabine—prostate cancer	8.39e-05	0.00103	CcSEcCtD
Methimazole—Body temperature increased—Capecitabine—prostate cancer	8.35e-05	0.00102	CcSEcCtD
Methimazole—Vomiting—Etoposide—prostate cancer	8.34e-05	0.00102	CcSEcCtD
Methimazole—Dyspepsia—Prednisone—prostate cancer	8.28e-05	0.00101	CcSEcCtD
Methimazole—Rash—Etoposide—prostate cancer	8.27e-05	0.00101	CcSEcCtD
Methimazole—Dermatitis—Etoposide—prostate cancer	8.27e-05	0.00101	CcSEcCtD
Methimazole—Headache—Etoposide—prostate cancer	8.22e-05	0.00101	CcSEcCtD
Methimazole—Vertigo—Epirubicin—prostate cancer	8.1e-05	0.000992	CcSEcCtD
Methimazole—Leukopenia—Epirubicin—prostate cancer	8.07e-05	0.000988	CcSEcCtD
Methimazole—Nausea—Etoposide—prostate cancer	7.79e-05	0.000955	CcSEcCtD
Methimazole—Pruritus—Docetaxel—prostate cancer	7.72e-05	0.000945	CcSEcCtD
Methimazole—Myalgia—Epirubicin—prostate cancer	7.67e-05	0.00094	CcSEcCtD
Methimazole—Arthralgia—Epirubicin—prostate cancer	7.67e-05	0.00094	CcSEcCtD
Methimazole—Vertigo—Doxorubicin—prostate cancer	7.49e-05	0.000918	CcSEcCtD
Methimazole—Urticaria—Prednisone—prostate cancer	7.47e-05	0.000915	CcSEcCtD
Methimazole—Pruritus—Capecitabine—prostate cancer	7.47e-05	0.000915	CcSEcCtD
Methimazole—Leukopenia—Doxorubicin—prostate cancer	7.46e-05	0.000914	CcSEcCtD
Methimazole—Body temperature increased—Prednisone—prostate cancer	7.43e-05	0.000911	CcSEcCtD
Methimazole—Oedema—Epirubicin—prostate cancer	7.36e-05	0.000901	CcSEcCtD
Methimazole—Thrombocytopenia—Epirubicin—prostate cancer	7.2e-05	0.000882	CcSEcCtD
Methimazole—Myalgia—Doxorubicin—prostate cancer	7.1e-05	0.00087	CcSEcCtD
Methimazole—Arthralgia—Doxorubicin—prostate cancer	7.1e-05	0.00087	CcSEcCtD
Methimazole—Vomiting—Docetaxel—prostate cancer	6.93e-05	0.000849	CcSEcCtD
Methimazole—Rash—Docetaxel—prostate cancer	6.88e-05	0.000842	CcSEcCtD
Methimazole—Dermatitis—Docetaxel—prostate cancer	6.87e-05	0.000841	CcSEcCtD
Methimazole—Headache—Docetaxel—prostate cancer	6.83e-05	0.000837	CcSEcCtD
Methimazole—Oedema—Doxorubicin—prostate cancer	6.81e-05	0.000834	CcSEcCtD
Methimazole—Vomiting—Capecitabine—prostate cancer	6.71e-05	0.000822	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Epirubicin—prostate cancer	6.7e-05	0.000821	CcSEcCtD
Methimazole—Thrombocytopenia—Doxorubicin—prostate cancer	6.66e-05	0.000816	CcSEcCtD
Methimazole—Rash—Capecitabine—prostate cancer	6.66e-05	0.000815	CcSEcCtD
Methimazole—Pruritus—Prednisone—prostate cancer	6.65e-05	0.000815	CcSEcCtD
Methimazole—Dermatitis—Capecitabine—prostate cancer	6.65e-05	0.000815	CcSEcCtD
Methimazole—Headache—Capecitabine—prostate cancer	6.61e-05	0.00081	CcSEcCtD
Methimazole—Paraesthesia—Epirubicin—prostate cancer	6.6e-05	0.000809	CcSEcCtD
Methimazole—Somnolence—Epirubicin—prostate cancer	6.54e-05	0.000801	CcSEcCtD
Methimazole—Nausea—Docetaxel—prostate cancer	6.48e-05	0.000793	CcSEcCtD
Methimazole—Dyspepsia—Epirubicin—prostate cancer	6.47e-05	0.000793	CcSEcCtD
Methimazole—Nausea—Capecitabine—prostate cancer	6.27e-05	0.000768	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Doxorubicin—prostate cancer	6.2e-05	0.00076	CcSEcCtD
Methimazole—Paraesthesia—Doxorubicin—prostate cancer	6.11e-05	0.000749	CcSEcCtD
Methimazole—Somnolence—Doxorubicin—prostate cancer	6.05e-05	0.000741	CcSEcCtD
Methimazole—Dyspepsia—Doxorubicin—prostate cancer	5.99e-05	0.000734	CcSEcCtD
Methimazole—Vomiting—Prednisone—prostate cancer	5.98e-05	0.000732	CcSEcCtD
Methimazole—Rash—Prednisone—prostate cancer	5.93e-05	0.000726	CcSEcCtD
Methimazole—Dermatitis—Prednisone—prostate cancer	5.92e-05	0.000726	CcSEcCtD
Methimazole—Headache—Prednisone—prostate cancer	5.89e-05	0.000722	CcSEcCtD
Methimazole—Urticaria—Epirubicin—prostate cancer	5.84e-05	0.000716	CcSEcCtD
Methimazole—Body temperature increased—Epirubicin—prostate cancer	5.81e-05	0.000712	CcSEcCtD
Methimazole—Nausea—Prednisone—prostate cancer	5.59e-05	0.000684	CcSEcCtD
Methimazole—Urticaria—Doxorubicin—prostate cancer	5.41e-05	0.000662	CcSEcCtD
Methimazole—Body temperature increased—Doxorubicin—prostate cancer	5.38e-05	0.000659	CcSEcCtD
Methimazole—Pruritus—Epirubicin—prostate cancer	5.2e-05	0.000637	CcSEcCtD
Methimazole—Pruritus—Doxorubicin—prostate cancer	4.82e-05	0.00059	CcSEcCtD
Methimazole—Vomiting—Epirubicin—prostate cancer	4.68e-05	0.000573	CcSEcCtD
Methimazole—Rash—Epirubicin—prostate cancer	4.64e-05	0.000568	CcSEcCtD
Methimazole—Dermatitis—Epirubicin—prostate cancer	4.63e-05	0.000568	CcSEcCtD
Methimazole—Headache—Epirubicin—prostate cancer	4.61e-05	0.000564	CcSEcCtD
Methimazole—Nausea—Epirubicin—prostate cancer	4.37e-05	0.000535	CcSEcCtD
Methimazole—Vomiting—Doxorubicin—prostate cancer	4.33e-05	0.00053	CcSEcCtD
Methimazole—Rash—Doxorubicin—prostate cancer	4.29e-05	0.000526	CcSEcCtD
Methimazole—Dermatitis—Doxorubicin—prostate cancer	4.29e-05	0.000525	CcSEcCtD
Methimazole—Headache—Doxorubicin—prostate cancer	4.26e-05	0.000522	CcSEcCtD
Methimazole—Nausea—Doxorubicin—prostate cancer	4.04e-05	0.000495	CcSEcCtD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.72e-06	2.62e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTA2—prostate cancer	2.72e-06	2.62e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP3A4—prostate cancer	2.71e-06	2.61e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—LPL—prostate cancer	2.71e-06	2.61e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.7e-06	2.6e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—HPGDS—prostate cancer	2.69e-06	2.59e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ABCG5—prostate cancer	2.68e-06	2.59e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.68e-06	2.59e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CYP1A1—prostate cancer	2.67e-06	2.58e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP2C19—prostate cancer	2.67e-06	2.57e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP1B1—prostate cancer	2.66e-06	2.57e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—ERCC2—prostate cancer	2.65e-06	2.55e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—SLC5A5—prostate cancer	2.65e-06	2.55e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—SLC5A5—prostate cancer	2.62e-06	2.53e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTA1—prostate cancer	2.62e-06	2.53e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CYP1A1—prostate cancer	2.62e-06	2.52e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ACHE—prostate cancer	2.6e-06	2.51e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTT1—prostate cancer	2.6e-06	2.51e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—ERCC2—prostate cancer	2.59e-06	2.5e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CG—prostate cancer	2.59e-06	2.5e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.59e-06	2.5e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTO1—prostate cancer	2.59e-06	2.5e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NAT2—prostate cancer	2.59e-06	2.5e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP2E1—prostate cancer	2.58e-06	2.49e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GGT1—prostate cancer	2.58e-06	2.49e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP2A6—prostate cancer	2.57e-06	2.48e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.56e-06	2.47e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP2E1—prostate cancer	2.56e-06	2.47e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—NQO1—prostate cancer	2.56e-06	2.46e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—NCOA1—prostate cancer	2.54e-06	2.45e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—NQO1—prostate cancer	2.53e-06	2.44e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—TH—prostate cancer	2.52e-06	2.43e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—AKR1C3—prostate cancer	2.5e-06	2.42e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP19A1—prostate cancer	2.5e-06	2.41e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—TH—prostate cancer	2.5e-06	2.41e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP3A4—prostate cancer	2.49e-06	2.4e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PRKACB—prostate cancer	2.49e-06	2.4e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—MTHFR—prostate cancer	2.49e-06	2.4e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PLCB2—prostate cancer	2.49e-06	2.4e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—LRP2—prostate cancer	2.49e-06	2.4e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.49e-06	2.4e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.48e-06	2.39e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP3A4—prostate cancer	2.47e-06	2.38e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP17A1—prostate cancer	2.47e-06	2.38e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.46e-06	2.37e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—INS—prostate cancer	2.45e-06	2.37e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP1B1—prostate cancer	2.45e-06	2.36e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PPARA—prostate cancer	2.44e-06	2.36e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—MTHFR—prostate cancer	2.44e-06	2.35e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—P4HB—prostate cancer	2.44e-06	2.35e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.43e-06	2.34e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP1B1—prostate cancer	2.43e-06	2.34e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—RXRA—prostate cancer	2.42e-06	2.33e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—CREBBP—prostate cancer	2.4e-06	2.32e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PPARA—prostate cancer	2.39e-06	2.31e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GGT1—prostate cancer	2.37e-06	2.29e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.37e-06	2.29e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GGT1—prostate cancer	2.35e-06	2.27e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.35e-06	2.27e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NCOA2—prostate cancer	2.35e-06	2.27e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—NCOA1—prostate cancer	2.34e-06	2.25e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—COMT—prostate cancer	2.33e-06	2.24e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GSTP1—prostate cancer	2.32e-06	2.23e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—NCOA1—prostate cancer	2.32e-06	2.23e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.31e-06	2.23e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP19A1—prostate cancer	2.3e-06	2.22e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CAV1—prostate cancer	2.3e-06	2.21e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP19A1—prostate cancer	2.28e-06	2.2e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ITPR1—prostate cancer	2.28e-06	2.2e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CD—prostate cancer	2.28e-06	2.2e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—MED12—prostate cancer	2.27e-06	2.19e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GNG5—prostate cancer	2.26e-06	2.17e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CAV1—prostate cancer	2.25e-06	2.17e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.24e-06	2.16e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SLC5A5—prostate cancer	2.24e-06	2.16e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—RXRA—prostate cancer	2.22e-06	2.14e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—RXRA—prostate cancer	2.2e-06	2.12e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP2E1—prostate cancer	2.19e-06	2.11e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NCOA3—prostate cancer	2.17e-06	2.09e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NQO1—prostate cancer	2.16e-06	2.09e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—TYMS—prostate cancer	2.15e-06	2.08e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—NOS3—prostate cancer	2.15e-06	2.08e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.14e-06	2.07e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—COMT—prostate cancer	2.14e-06	2.06e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—TH—prostate cancer	2.13e-06	2.06e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GSTP1—prostate cancer	2.13e-06	2.05e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GSTM1—prostate cancer	2.13e-06	2.05e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—COMT—prostate cancer	2.12e-06	2.05e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.12e-06	2.04e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GSTP1—prostate cancer	2.11e-06	2.04e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP3A4—prostate cancer	2.11e-06	2.04e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.1e-06	2.03e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ITPR1—prostate cancer	2.1e-06	2.02e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CG—prostate cancer	2.09e-06	2.02e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—LPL—prostate cancer	2.09e-06	2.02e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ITPR1—prostate cancer	2.08e-06	2e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP1B1—prostate cancer	2.08e-06	2e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—HPGDS—prostate cancer	2.07e-06	2e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.06e-06	1.99e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CG—prostate cancer	2.05e-06	1.98e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.04e-06	1.97e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP1A1—prostate cancer	2.02e-06	1.95e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTT1—prostate cancer	2.01e-06	1.94e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ACHE—prostate cancer	2.01e-06	1.94e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GGT1—prostate cancer	2.01e-06	1.94e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ERCC2—prostate cancer	2e-06	1.93e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.99e-06	1.92e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CB—prostate cancer	1.99e-06	1.92e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—TYMS—prostate cancer	1.98e-06	1.91e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—INS—prostate cancer	1.98e-06	1.91e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NCOA1—prostate cancer	1.98e-06	1.91e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PTGS2—prostate cancer	1.97e-06	1.9e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—TYMS—prostate cancer	1.96e-06	1.89e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GSTM1—prostate cancer	1.96e-06	1.89e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.95e-06	1.88e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GSTM1—prostate cancer	1.94e-06	1.87e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CREBBP—prostate cancer	1.94e-06	1.87e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—INS—prostate cancer	1.94e-06	1.87e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.93e-06	1.86e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PRKACB—prostate cancer	1.92e-06	1.85e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—LPL—prostate cancer	1.92e-06	1.85e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—LPL—prostate cancer	1.91e-06	1.84e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.9e-06	1.83e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CREBBP—prostate cancer	1.9e-06	1.83e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—RXRA—prostate cancer	1.88e-06	1.82e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—MTHFR—prostate cancer	1.88e-06	1.81e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.86e-06	1.79e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PPARA—prostate cancer	1.85e-06	1.78e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ERCC2—prostate cancer	1.84e-06	1.78e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.84e-06	1.77e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CD—prostate cancer	1.84e-06	1.77e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.83e-06	1.77e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ERCC2—prostate cancer	1.83e-06	1.76e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—COMT—prostate cancer	1.81e-06	1.75e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NCOA2—prostate cancer	1.81e-06	1.75e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTP1—prostate cancer	1.81e-06	1.74e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CD—prostate cancer	1.8e-06	1.74e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ITPR1—prostate cancer	1.78e-06	1.71e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.75e-06	1.68e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—NOS3—prostate cancer	1.74e-06	1.67e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CAV1—prostate cancer	1.74e-06	1.67e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—MTHFR—prostate cancer	1.73e-06	1.67e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.73e-06	1.67e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PTEN—prostate cancer	1.72e-06	1.66e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—MTHFR—prostate cancer	1.72e-06	1.65e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—NOS3—prostate cancer	1.7e-06	1.64e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PPARA—prostate cancer	1.7e-06	1.64e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.69e-06	1.63e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PPARA—prostate cancer	1.68e-06	1.62e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—TYMS—prostate cancer	1.68e-06	1.62e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NQO1—prostate cancer	1.67e-06	1.61e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTM1—prostate cancer	1.66e-06	1.6e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.66e-06	1.6e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—TH—prostate cancer	1.65e-06	1.59e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—EP300—prostate cancer	1.64e-06	1.58e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—LPL—prostate cancer	1.63e-06	1.57e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CB—prostate cancer	1.6e-06	1.55e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.6e-06	1.54e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CAV1—prostate cancer	1.6e-06	1.54e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PTGS2—prostate cancer	1.59e-06	1.53e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CAV1—prostate cancer	1.58e-06	1.53e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.58e-06	1.52e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.57e-06	1.52e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CB—prostate cancer	1.57e-06	1.51e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ERCC2—prostate cancer	1.56e-06	1.5e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PTGS2—prostate cancer	1.56e-06	1.5e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GGT1—prostate cancer	1.55e-06	1.5e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NCOA1—prostate cancer	1.53e-06	1.47e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.51e-06	1.46e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.51e-06	1.45e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—INS—prostate cancer	1.5e-06	1.44e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—MTHFR—prostate cancer	1.47e-06	1.41e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CREBBP—prostate cancer	1.47e-06	1.41e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.45e-06	1.4e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—RXRA—prostate cancer	1.45e-06	1.4e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.44e-06	1.39e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PPARA—prostate cancer	1.44e-06	1.39e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—COMT—prostate cancer	1.4e-06	1.35e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTP1—prostate cancer	1.39e-06	1.34e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.39e-06	1.34e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PTEN—prostate cancer	1.39e-06	1.34e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—INS—prostate cancer	1.38e-06	1.33e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ITPR1—prostate cancer	1.37e-06	1.32e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—INS—prostate cancer	1.36e-06	1.32e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PTEN—prostate cancer	1.36e-06	1.31e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CAV1—prostate cancer	1.35e-06	1.3e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CREBBP—prostate cancer	1.35e-06	1.3e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CREBBP—prostate cancer	1.34e-06	1.29e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—EP300—prostate cancer	1.32e-06	1.27e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—NOS3—prostate cancer	1.31e-06	1.27e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—TYMS—prostate cancer	1.3e-06	1.25e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—EP300—prostate cancer	1.29e-06	1.25e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.29e-06	1.25e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTM1—prostate cancer	1.28e-06	1.23e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.28e-06	1.23e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.27e-06	1.22e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—LPL—prostate cancer	1.26e-06	1.21e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.23e-06	1.19e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.21e-06	1.17e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.21e-06	1.17e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CA—prostate cancer	1.21e-06	1.17e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—NOS3—prostate cancer	1.21e-06	1.16e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ERCC2—prostate cancer	1.2e-06	1.16e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PTGS2—prostate cancer	1.2e-06	1.16e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—NOS3—prostate cancer	1.2e-06	1.15e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—INS—prostate cancer	1.17e-06	1.12e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CREBBP—prostate cancer	1.14e-06	1.1e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—MTHFR—prostate cancer	1.13e-06	1.09e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.11e-06	1.07e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PPARA—prostate cancer	1.11e-06	1.07e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.1e-06	1.07e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PTGS2—prostate cancer	1.1e-06	1.06e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PTGS2—prostate cancer	1.09e-06	1.06e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.08e-06	1.04e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PTEN—prostate cancer	1.05e-06	1.01e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CAV1—prostate cancer	1.04e-06	1.01e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NOS3—prostate cancer	1.02e-06	9.86e-06	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—EP300—prostate cancer	9.98e-07	9.63e-06	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—AKT1—prostate cancer	9.9e-07	9.54e-06	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CA—prostate cancer	9.77e-07	9.42e-06	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PTEN—prostate cancer	9.63e-07	9.28e-06	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CA—prostate cancer	9.57e-07	9.23e-06	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PTEN—prostate cancer	9.55e-07	9.2e-06	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CG—prostate cancer	9.51e-07	9.17e-06	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CB—prostate cancer	9.44e-07	9.1e-06	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PTGS2—prostate cancer	9.35e-07	9.02e-06	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—EP300—prostate cancer	9.18e-07	8.85e-06	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—EP300—prostate cancer	9.1e-07	8.78e-06	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—INS—prostate cancer	9e-07	8.68e-06	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CREBBP—prostate cancer	8.82e-07	8.5e-06	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CD—prostate cancer	8.36e-07	8.06e-06	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PTEN—prostate cancer	8.16e-07	7.87e-06	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—AKT1—prostate cancer	7.98e-07	7.7e-06	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NOS3—prostate cancer	7.89e-07	7.61e-06	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—AKT1—prostate cancer	7.82e-07	7.54e-06	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—EP300—prostate cancer	7.78e-07	7.5e-06	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CA—prostate cancer	7.39e-07	7.12e-06	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CB—prostate cancer	7.29e-07	7.02e-06	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PTGS2—prostate cancer	7.22e-07	6.96e-06	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CA—prostate cancer	6.79e-07	6.55e-06	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CA—prostate cancer	6.73e-07	6.49e-06	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PTEN—prostate cancer	6.3e-07	6.07e-06	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—AKT1—prostate cancer	6.03e-07	5.82e-06	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—EP300—prostate cancer	6e-07	5.79e-06	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CA—prostate cancer	5.75e-07	5.55e-06	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—AKT1—prostate cancer	5.55e-07	5.35e-06	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—AKT1—prostate cancer	5.5e-07	5.3e-06	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—AKT1—prostate cancer	4.7e-07	4.53e-06	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.44e-07	4.28e-06	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—AKT1—prostate cancer	3.63e-07	3.5e-06	CbGpPWpGaD
